You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
| Title |
FemZone trial: a randomized phase II trial comparing neoadjuvant letrozole and zoledronic acid with letrozole in primary breast cancer patients
|
|---|---|
| Published in |
BMC Cancer, February 2014
|
| DOI | 10.1186/1471-2407-14-66 |
| Pubmed ID | |
| Authors |
Peter A Fasching, Sebastian M Jud, Maik Hauschild, Sherko Kümmel, Martin Schütte, Matthias Warm, Volker Hanf, Dieter Grab, Jutta Krocker, Elmar Stickeler, Rolf Kreienberg, Thomas Müller, Thorsten Kühn, Christopher Wolf, Steffen Kahlert, Stefan Paepke, Michael Berghorn, Mathias Muth, Monika Baier, Birgit Wackwitz, Rüdiger Schulz-Wendtland, Matthias W Beckmann, Michael P Lux |
Mendeley readers
The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 36 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 7 | 19% |
| Student > Bachelor | 5 | 14% |
| Student > Ph. D. Student | 4 | 11% |
| Researcher | 3 | 8% |
| Student > Master | 3 | 8% |
| Other | 5 | 14% |
| Unknown | 9 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 17 | 47% |
| Nursing and Health Professions | 3 | 8% |
| Decision Sciences | 2 | 6% |
| Sports and Recreations | 1 | 3% |
| Social Sciences | 1 | 3% |
| Other | 1 | 3% |
| Unknown | 11 | 31% |